UBS has recently reduced Royalty Pharma plc (RPRX) stock to Neutral rating, as announced on June 3, 2024, according to Finviz. Earlier, on June 14, 2022, UBS had resumed the stock to Buy, setting a ...

Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults ...

This approval triggers 2 milestone payments totaling $29 million, as per agreements with Royalty Pharma and PureTech's founded entity, Karuna Therapeutics, which was acquired by Bristol Myers Squibb ...

PureTech Health PLC on Friday said KarXT has received US Food & Drug Administration approval for treating schizophrenia. The Boston, Massachusetts-based biotechnology company said the milestone ...

The pound was quoted at USD1.3366 early on Friday in London, compared to USD1.3412 at the equities close on Thursday. The euro stood at USD1.1135, lower against USDUSD1.1179. Against the yen, the ...

Bristol-Myers Squibb (BMY) shares rose early Friday as the biopharmaceutical company obtained approval from the US Food and Drug Administration for its Cobenfy drug to treat schizophrenia in adults.

Phathom Pharmaceuticals developed Voquezna, a first-in-class PCAB, licensed from Takeda, for acid-related disorders. Find out ...

Mankind Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Royalty Income for the year ending 31-Mar-2024.For the quarter ended 30-06-2024, the company has ...

Despite revenue and cash flow declines, Franco-Nevada reported record margins with an 88.7% cash margin, benefiting from ...

Danaos’ (DAC) current dividend yield is over 3.7%, making it a suitable portfolio addition for many investors. Also, with its ...

During economic uncertainty, dividend growth stocks are a smart choice for stable passive income, inflation protection, and ...

Westlife Foodworld shares soared, driven by a surge in trading volume, as the company grapples with a challenging operating ...